Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) have been shown to differentiate into primordial germ cells (PGCs) but not into spermatogonia, haploid spermatocytes, or spermatids. Here, we show that hESCs and hiPSCs differentiate directly into advanced male germ cell lineages, including postmeiotic, spermatid-like cells, in vitro without genetic manipulation. Furthermore, our procedure mirrors spermatogenesis in vivo by differentiating PSCs into UTF1-, PLZF-, and CDH1-positive spermatogonia-like cells; HIWI-and HILIpositive spermatocyte-like cells; and haploid cells expressing acrosin, transition protein 1, and protamine 1 (proteins that are uniquely found in spermatids and/or sperm). These spermatids show uniparental genomic imprints similar to those of human sperm on two loci: H19 and IGF2. These results demonstrate that male PSCs have the ability to differentiate directly into advanced germ cell lineages and may represent a novel strategy for studying spermatogenesis in vitro.
INTRODUCTION
Infertility affects $15% of couples, with male factors responsible for 40%-60% of cases of infertility (Schlegel, 2009) . For men without a genetic cause of infertility, stem cell transplantation represents a possible treatment option (Marques-Mari et al., 2009; Mathews et al., 2009; Yao et al., 2011) . Protocols to preserve future fertility in boys who are undergoing cancer therapies and cannot yet bank their own sperm are under development (Hermann et al., 2007; Sadri-Ardekani et al., 2011; Schlatt et al., 2009 ). However, for adult and prepubescent patients who have been rendered sterile prior to sperm collection, no treatments to restore fertility are currently available.
Mouse embryonic stem cells (ESCs) (Geijsen et al., 2004; Hayashi et al., 2011) , nonhuman primate (NHP) ESCs, and human ESCs (hESCs) (Bucay et al., 2009; Fukunaga et al., 2010; Kee et al., 2009; Panula et al., 2011; Park et al., 2009; Teramura et al., 2007; Tilgner et al., 2008; Yamauchi et al., 2009 ) have been differentiated into primordial germ cells (PGCs), fetal precursors of the spermatogenic lineage. In addition, recent studies suggest that human pluripotent stem cells (hPSCs) can enter meiosis and in some cases produce haploid products (Eguizabal et al., 2011; Kee et al., 2009; Panula et al., 2011) . In this study, we developed an in vitro method that achieves two significant endpoints. First, male hESCs and human induced PSCs (hiPSCs) differentiate directly into adult-type spermatogonia. Second, differentiating stem cells give rise to cells that are phenotypically similar to postmeiotic round spermatids. These results highlight the full plasticity of hPSCs by showing their ability to undergo spermatogenesis in vitro, culminating with haploid round spermatid-like cells. These results also contribute to the overall goal of both understanding germ cell development in vitro and ultimately generating gametes that may prove invaluable for understanding infertility mechanisms.
RESULTS

Mouse Spermatogonial Stem Cell Conditions Elevate the Expression of Germ Cell Markers
Previous studies have shown that human testis cells cultured in PSC conditions directly dedifferentiate into PSCs (Conrad et al., 2008; Ko et al., 2009; Kossack et al., 2009 ). Thus, we examined whether ESCs could directly differentiate into germline stem cells. Our goal was to differentiate PSCs into spermatogonial stem cell (SSC)-like cells, because this spermatogenic lineage has shown an exceptional ability to recolonize sterilized testes and thus restore fertility in certain species, including mice and NHPs (Brinster and Avarbock, 1994; Jahnukainen et al., 2011) . One advantage of this strategy is that there are established protocols for culturing and expanding rodent SSCs in vitro (Kanatsu-Shinohara et al., 2003) . We cultured H1 (WA01) hESCs and human foreskin fibroblast 1 (HFF1) iPSCs directly in standardized mouse SSC culture conditions. After a 10 day culture, we observed significant increases in VASA+ cells, with $60% of H1 cells and $40% of HFF1 cells expressing VASA (Figures 1A and 1B and enlarged insets) . These VASA+, germlike cells showed typical VASA staining patterns as seen in human testis sections ( Figure S1A ). Day 10 was the optimum time point, because day 7 cultures yielded lower numbers of VASA+ cells and day 15 cultures did not yield an appreciable increase ( Figure S1B ). In comparison with previous protocols, we observed a 4-to 5-fold increase in VASA+ cells derived from hPSCs, all within 10 days postdifferentiation.
We further analyzed H1 and HFF1 cells cultured in mouse SSC conditions (termed H1 SSC and HFF1 SSC, respectively) for expression of additional germ cell markers. Deleted-in-Azoospermia-like (DAZL) and VASA are two germline-specific, RNAbinding proteins that are important in germ cell development and normal spermatogenesis (Castrillon et al., 2000; Kee et al., 2009) . Recently, Kee et al. (2009) showed that some hESCs, mainly female lines, express low levels of VASA mRNA. Here, both male hESC and hiPSC lines did not exhibit expression of VASA mRNA ( Figure 1C ). H1 SSC and HFF1 SSC cells showed an increase in all germ cell markers tested, including CXCR4 and PIWIL1, by reverse transcriptase (RT)-PCR, suggesting that this is an efficient way to generate germ cell lineages ( Figure 1C ). VASA and DAZL protein expression was also elevated in H1 SSCs and HFF1 SSCs compared with the undifferentiated, parent PSC lines ( Figure 1D ). We also observed that germ cell differentiation was dependent on the growth factor glial-derived neurotrophic factor (GDNF; hPSCs + Complete). Cells differentiated without GDNF (hPSCs + fibroblast growth factor [FGF] only) demonstrated no increase in VASA or DAZL protein expression but did show a loss of the pluripotent marker Nanog, suggesting that both H1 hESCs and HFF1 hiPSCs differentiated ( Figure 1D ). These results suggest that GDNF containing SSC medium efficiently and rapidly differentiates hPSCs into germ cell lineages.
hPSCs Cultured in Mouse SSC Conditions Express PLZF CXCR4 is a chemokine receptor that is expressed by spermatogonia and plays a role in SSC maintenance (Payne et al., 2010) . Because we detected elevations in CXCR4 in both H1 SSCs and HFF1 SSCs ( Figure 1C ), we next evaluated whether H1 SSCs and HFF1 SSCs expressed PLZF, a zinc-finger transcription factor that is a consensus marker of stem and progenitor spermatogonia. PLZF, or ZBTB16, plays a critical role in SSC self-renewal and growth (Buaas et al., 2004; Costoya et al., 2004; Hobbs et al., 2010) . A 10 day culture in mouse SSC conditions induced expression of PLZF, localized to the nucleus, in both H1 and HFF1 SSCs ( Figure 2 ). This nuclear expression of PLZF mirrors that observed in human testes ( Figure 2 , row 7). Furthermore, our protocol generates a high percentage of PLZF-positive cells within differentiating colonies (Figure 2 , low-magnification views, rows 3 and 6), with $82% of H1 SSCs and $78% HFF1 SSCs expressing PLZF ( Figure S2A ). Unlike other methods, our protocol induces PLZF expression ( Figure S2B ). This suggests that we are more closely mirroring the early events of in vivo spermatogenesis.
SSC Conditions Yield Postmeiotic, Acrosin-Positive Cells
SSCs are defined in part by their ability to produce gametes through a complex combination of division and differentiation.
Mouse SSCs can differentiate into haploid cells in vitro (Feng et al., 2002) , so we next quantified whether haploid cells were produced in H1 SSCs and HFF1 SSCs. Flow cytometry analyses indicated that a haploid population exists in H1 SSCs (4.5%) and HFF1 SSCs (3.9%) corresponding to haploid peaks observed with human sperm ( Figure 3A; Figure S3A) . We further confirmed haploidy of isolated cells by fluorescence in situ hybridization (FISH) with a locked nucleic acid (LNA) probe to satellite DNA found on chromosomes 1, 9, 16, and Y ( Figure S3C ). After fluorescence-activated cell sorting (FACS), the majority of haploid cells isolated from both H1 SSCs and HFF1 SSCs exhibited polar acrosin localization ( Figure 3B , enlarged insets; Figure S3B ). These results suggest that we are able to generate a small percentage of acrosin-positive, haploid cells in vitro from hPSCs within 10 days of SSC culture. Ten days proved to be optimal because haploid cell production decreased after 20 days ( Figure S3D ).
hPSC Differentiation in SSC Conditions Generates Cells that Express Markers for Spermatogonia, Premeiotic Spermatocytes, Postmeiotic Spermatocytes, and Round Spermatids Because differentiation in SSC conditions altered cell-cycle profiles ( Figures S4A and S4B ) and yielded a small percentage of haploid cells in addition to a large population of PLZF-positive spermatogonia, we next evaluated whether H1 ESCs and HFF1 iPSCs differentiated into intermediate cell types observed in in vivo spermatogenesis. In addition to PLZF, we observed expression of UTF1 and CDH1 ( Figure 4A , left column), proteins that are expressed in both spermatogonia and PSCs. In contrast to the PSCs, we observed an increase in protein expression of RET and GFRa1 ( Figure 4A , western blots), receptors for GDNF that are found on spermatogonia.
Differentiation of hPSCs in SSC conditions showed an increase in PIWIL1 RNA expression ( Figure 1C) . PIWIL1 (also known as HIWI) is essential in spermatogenic progression from SSCs to round spermatids (Deng and Lin, 2002) . We examined the expression of three spermatocyte markers for premeiotic spermatocytes/differentiating spermatogonia, meiotic spermatocytes, and postmeiotic spermatocytes. We identified cells in both differentiating H1 ESCs and HFF1 iPSCs expressing premeiotic HILI protein, the meiotic marker synaptonemal complex 3 (SYCP3, which is involved in recombination and segregation of meiotic chromosomes), and postmeiotic HIWI ( Figure 4A , center column). Although there were a large number of HILI-positive cells, very few cells expressed SYCP3 or HIWI, suggesting that there is bottleneck prior to meiosis.
We next isolated cells from the haploid peaks by FACS and immunostained these cells for spermatid markers. During spermiogenesis, acrosin expression is turned on and histones are replaced by protamines via transition proteins (Carrell et al., 2007) . Haploid cells isolated from H1 and HFF1 SSC cultures express the postmeiotic sperm markers acrosin, protamine 1 (Prot1), and transition protein 1 (TP1; Figure 4 , right column). In particular, acrosin staining exhibits polar localization in both cell lines ( Figure 4A, row 1) . These haploid cells resemble round spermatids by acrosin localization, the nuclear/perinuclear localization of TP1, and the perinuclear localization of Prot1 ( Figure 4A , right column), which localizes to the perinuclear region of haploid cells and enters the nucleus at the elongated spermatid stage (Carrell et al., 2007) . All acrosin-positive cells were also positive for TP1 ( Figure S4C ). These haploid cells also resemble round spermatids observed in humans and NHPs (Carrell et al., 2007; Moreno et al., 2006; Ramalho-Santos et al., 2002 ; also see Figure S4D ). These results coupled with the above PIWIL1 expression data suggest that PSCs are able to differentiate directly into postmeiotic, round, spermatid-like cells in vitro.
During in vivo germ cell specification, genomic imprints are removed at the primordial germ cell stage and then reestablished during spermatogenesis (Lucifero et al., 2002) . In mice, differentiation of PSCs into functional germ cells results in progeny that exhibit epigenetic disease phenotypes (Nayernia et al., 2006; Nolte et al., 2010) . It was proposed that this may be due to improper imprinting during gametogenesis (Lucifero and Reik, 2006) . To evaluate imprinting statuses on the haploid spermatids differentiated here, we isolated haploid cells by FACS and examined the methylation status of the imprinting control region (ICR) for paternally imprinted (H19) and maternally imprinted (IGF2) genes. As previously reported, iPSCs showed aberrant imprinting (Pick et al., 2009 ), but ESCs showed typical somatic cell imprinting on ICRs for H19 and IGF2 ( Figure 4B ). Isolation of haploid cells from H1 SSC cultures showed imprinting patterns similar to those observed in human sperm, with H19 ICR methylation of $90% and IGF2 ICR methylation of $5% ( Figure 4B ). Haploid cells from HFF1 SSCs showed levels of H19 ICR methylation similar to those observed in human sperm ($90%), but IGF2 methylation ($14%) was slightly elevated above that observed in human sperm ( Figure 4B ). These results suggest that the haploid products obtained show similar DNA methylation patterns on at least two parent-of-origin genomic imprints.
DISCUSSION
Several studies have shown that hPSCs differentiate in vitro and in vivo into the three germ layers (endoderm, mesoderm, and ectoderm). However, only recently have studies shown that hPSCs exhibit greater plasticity by differentiating into germ cell lineages. Our study shows that male diploid PSCs differentiate into advanced haploid lineages, including round spermatids. Although female PSCs do not differentiate and undergo cell death in our protocol (data not shown), methods have been developed to generate haploid oocyte-like cells from female lines (for review, see Virant-Klun et al., 2011) , furthering demonstrating that both male and female PSCs possess the potential to differentiate into any adult cell type, including gametes.
The generation of viable sperm and spermatids in vitro from PSCs and even somatic cells in humans and other primates has many biomedical justifications even though the endeavor is fraught with experimental and bioethical challenges (Daley, 2007) . Furthermore, the stringency with which these in vitro sperm are evaluated varies according the necessary endpoint. The greatest stringency is required for the generation of fully functional sperm or spermatids that would be considered useful and safe for fertilization in assisted reproductive technology (ART) clinics. This objective is justified by the Oncofertility Consortium, which pursues the benevolent goal of preserving fertility in male cancer survivors who have been rendered infertile during their therapies but are also too young or fragile to produce a sperm specimen for cryobanking (Woodruff, 2010) . It is also supported by ART practitioners for the potential treatment of men with either diagnosed or idiopathic infertility who cannot provide either sperm or elongated spermatids. Discovering the stages during spermatogenesis at which various forms of idiopathic male infertility arrest would greatly aid in the diagnosis of (and perhaps the development of treatments for) these still mysterious processes. Knowledge about these spermatogenic arrest sites might also contribute to the design of novel contraceptives. In addition, the epigenetic modifications that enable the properly imprinted sperm chromatin and the replacement of nuclear proteins to form the sperm nucleus could be better investigated in these types of cell cultures versus in intact tissues, especially since our protocol seems to generate haploid products with parent-of-origin imprints similar to those observed in fertile human sperm. Anticipated improvements in the efficiency of in vitro spermatogenesis may also help elucidate how mitochondria are modified to create the sperm mitochondria, and how the somatic centrosome is reduced during male meiosis to form the sperm tail's basal body and the sperm centrosome (Schatten, 1994) .
Differentiating hPSCs into SSCs is an important step in evaluating the possibility of transplanting patient-specific PSCs or SSCs to restore fertility. The ability to differentiate hPSCs directly into SSCs without having to go through a PGC differentiation protocol is likewise important for decreasing differentiation strategy time frames to increase utilization within a clinical setting. Furthermore, differentiation in SSC conditions yielded several cell types that are observed during spermatogenesis, suggesting that ultimately, patient-specific spermatogenesis can be studied in vitro with only PSCs. We observed the expression of putative markers for spermatogenesis, including markers for undifferentiated spermatogonia, differentiating spermatogonia, premeiotic spermatocytes, meiotic and postmeiotic spermatocytes, and spermatids. In contrast to published results (Bucay et al., 2009; Fukunaga et al., 2010; Kee et al., 2009; Panula et al., 2011; Park et al., 2009; Teramura et al., 2007; Tilgner et al., 2008; Yamauchi et al., 2009 ), our study not only outlines an approach for generating large numbers of VASA+ cells but also describes a method for rapidly and directly differentiating hPSCs into advanced germ cell lineages, including round spermatids, using only extrinsic factors with no genetic manipulation. Thus, the differentiation method presented here may contribute to the overall objective of using patient-specific hiPSCs to generate germ cell lineages capable of restoring fertility in sterile male patients.
Complete spermatogenesis in vitro has not yet been accomplished in humans. Because this strategy attempts to mimic in vivo spermatogenesis by generating undifferentiated spermatogonia as well as haploid round spermatids, it provides evidence that studying spermatogenesis through the round spermatid stage in vitro is feasible; however, additional work is needed to confirm that an individual cell progresses through all premeiotic, meiotic, and postmeiotic stages. Although techniques for using round spermatids to fertilize oocytes have not been proven in humans and NHPs, this protocol may allow researchers to study cytoplasmic events during early spermatogenesis from hPSCs to SSCs, as well as to characterize events associated with spermiogenesis to the round spermatid stage.
Our differentiation scheme may also represent a tool for exploring the root causes of male factor infertility. By deriving hiPSCs from infertile men, such as patients with Sertoli-cellonly (SCO) syndrome, followed by direct differentiation with our protocol, we could examine where spermatogenesis arrests, and in the case of SCO patients, identify whether hiPSCs can differentiate into SSCs and whether viability of SSCs is a major concern. Advances such as these would undoubtedly shed new light on the root causes of male factor infertility and clarify whether multiple disorders contribute to a patient's infertility. These potential clinical applications thus underscore the importance of improving our differentiation protocol to increase the efficiency of haploid cell generation as well as progressing further through spermiogenesis. It will be important to evaluate preclinically whether these in-vitro-generated gamete precursors have reproductive capabilities in vivo that will be helpful for infertility patients; however, these cells will be of keen biological importance regardless.
EXPERIMENTAL PROCEDURES
Mouse SSC Differentiation Medium and FACS H1 (WA01, WiCell) hESCs and HFF1 (parent fibroblasts from ATCC, iPS derived internally) (Easley et al., 2012) hiPSCs were cultured for 10 days in mouse SSC medium containing (all from Sigma, unless otherwise noted) minimum essential medium (MEM) alpha (Invitrogen), 0.2% bovine serum albumin, 5 mg/ml insulin, 10 mg/ml transferrin, 60 mM putrescine, 2 mM L-glutamine (Invitrogen), 50 mM b-mercaptoethanol, 1 ng/ml human basic FGF (hbFGF; BD Biosciences), 20 ng/ml GDNF (R&D Systems), 30 nM sodium selenite, 2.36 mM palmitic acid, 0.21 mM palmitoleic acid, 0.88 mM stearic acid, 1.02 mM oleic acid, 2.71 mM linoleic acid, 0.43 mM linolenic acid, 10 mM HEPES, and 0.5X penicillin/streptomycin (Invitrogen). To isolate haploid cells by FACS, H1 SSCs and HFF1 SSCs were stained with Vybrant DyeCycle Violet live-cell stain (Invitrogen) in the SSC medium described above but substituting OptiMeM with no phenol red and run on a FACS Aria sorter (BD Biosciences). Haploid cells were then cultured on poly-D-lysine-coated coverslips and fixed with 4% paraformaldehyde prior to immunostaining.
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